Welcome to our dedicated page for Greenway Greenho news (Ticker: GWAYF), a resource for investors and traders seeking the latest updates and insights on Greenway Greenho stock.
Greenway Greenhouse Cannabis Corporation (GWAYF) operates as a federally licensed producer of premium cannabis, combining agricultural expertise with advanced greenhouse cultivation in Kingsville, Ontario. This page serves as the definitive source for tracking the company's latest developments across wholesale operations, consumer brands, and international expansion efforts.
Investors and industry observers will find comprehensive coverage of earnings reports, product launches, quality certifications, and strategic acquisitions. The curated news collection emphasizes Greenway's operational milestones, including its MillRite pre-roll innovations and compliance with WHO-aligned GACP standards for global distribution.
All content is organized to highlight business-critical updates while maintaining accessibility for both professional analysts and casual investors. Key focus areas include production efficiency improvements, new market entries, and evolving CPG offerings within Canada's competitive cannabis landscape.
Bookmark this page for streamlined access to Greenway's official communications and third-party analysis. Regular updates ensure stakeholders maintain current awareness of the company's progress in sustainable cultivation and consumer product development.
Greenway Greenhouse Cannabis (CSE: GWAY) (OTCQB: GWAYF) has surpassed 30,000 KG of cannabis product sold since its inception, highlighting the company's growth and market demand. CEO Jamie D'Alimonte emphasized Greenway's strategic positioning in the evolving cannabis industry, noting they have quadrupled growing capacity and are prepared for further expansion if demand continues to rise.
The company also reported results from its recent Annual General Meeting, where shareholders re-elected Jamie D'Alimonte, Carl Mastronardi, Dennis Staudt, and Marty Komsa as Directors. MNP was reappointed as auditors, and the company's rolling stock option plan was approved. President Carl Mastronardi expressed gratitude for shareholder support and anticipates significant company developments in the coming year.
Greenway Greenhouse Cannabis (CSE: GWAY, OTCQB: GWAYF) reported record-breaking financial results for Q1 2024 ended June 30. Highlights include:
- Net revenue of $2,394,159, up 104% year-over-year
- Positive Adjusted EBITDA of $316,431, compared to $16,408 in Q1 2023
- Positive net cash flow from operations of $55,418
- 2,153,628 grams of cannabis sold, a 94% increase year-over-year
- Average cash cost per gram of $0.73
The company attributes its success to quality cannabis production, strategic partnerships, and efficient operations. Greenway's MillRite pre-rolls ranked second in sales for their category in Ontario, and the company completed its first harvest for international markets.
Greenway Greenhouse Cannabis (CSE: GWAY) (OTCQB: GWAYF) reported its audited annual financial statements for the year ended March 31, 2024. Key highlights include:
- Total grams sold increased 33% to 5,548,692
- Net revenue decreased 7% to $5,230,194
- Q4 net revenue increased 9% year-over-year to $1,482,194
- Average cash cost per gram of $0.74, within management's target
- Liabilities decreased 59% to $1,390,240
- Closed $3,500,000 private placement
- Launched first consumer products in Ontario
The company noted challenging market conditions but saw prices rebound in Q4. Greenway is expanding into international cannabis and domestic consumer markets to diversify revenue streams and increase value per gram produced.
Greenway Greenhouse Cannabis (CSE: GWAY) (OTCQB: GWAYF) announced the launch of Pink Moon, a new product in their MillRite line, available in Ontario. Pink Moon will be offered in a 2 x 0.5 gram pre-roll format. MillRite is now the #2 ranked brand of pre-rolls in Ontario by total retail sales, and its Lavender Haze pre-rolls have achieved a similar ranking over the past three months. The addition of Pink Moon provides both Indica and Sativa options in the Ontario market. Greenway aims to capture a larger share of the cannabis market, which comprises over 60% of sales in the whole flower and pre-roll segments.